AstraZeneca Resumes Its COVID-19 Vaccine Trials In The U.K.
The company had placed its worldwide vaccine trials on hold for several days. It now says a safety review by regulators and reviewers is complete. No word on when studies in the U.S. might resume.
Drugmaker AstraZeneca announced Saturday that its COVID-19 vaccine studies have resumed in the United Kingdom, though not yet in the United States. The vaccine trials had been placed on hold around theafter a U.K. participant in one of the studies developed a neurological illness.
